“Membrane‐Associated” Immunoglobulins in Cyst and Ascites Fluids of Ovarian Cancer Patients *

No abstract is available for this paper.

• Publication year

  1983

• Venue

  American Journal of Reproductive Immunology

• Publication date

  1983-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1600-0897.1983.tb00204.xPMID 6859379
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer immunology: the search for specificity.

  1982cited by this paper
• Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.

  1981cited by this paper
• Binding of specific peroxidase-labeled antibody to placental-type phosphatase on tumor-derived membrane fragments.

  1980cited by this paper
• Cross-reactions between cell surface membrane antigens of human trophoblast and cancer cells.

  1980cited by this paper
• Shedding from the cell surface of normal and cancer cells.

  1980cited by this paper
• Humoral and cellular immunity in long-term surviving patients with malignant lymphoma.

  1980cited by this paper
• Quantitation of peroxidase-antibody binding to membrane fragments using column chromatography.

  1979cited by this paper
• Rigid plasma‐membrane‐derived vesicles, enriched in tumour‐associated surface antigens (MLr), occurring in the ascites fluid of a murine leukaemia (GRSL)

  1979cited by this paper
• Detection of humoral immune response to human brain tumors. Specificity and reliability of microcytotoxicity assay

  1979cited by this paper
• Expression of cell-mediated immunity and blocking factor using a new line of ovarian cancer cells in vitro.

  1979cited by this paper
• Serological analysis of cell surface antigens of malignant human brain tumors.

  1978cited by this paper
• Spontaneous shedding of plasma membrane fragments by human cells in vivo and in vitro.

  1977cited by this paper
• Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells

  1977cited by this paper
• Micro mixed hemadsorption assay--a sensitive method for detecting antibodies against tumor-associated antigens.

  1977cited by this paper
• Comparison of multiple assays for detecting human antibodies directed against surface antigens on normal and malignant human tissue culture cells.

  1977cited by this paper
• Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics

  1977cited by this paper
• L-p-Bromotetramisole, a new reagent for use in measuring placental or intestinal isoenzymes of alkaline phosphatase in human serum.

  1977cited by this paper
• An examination of the immunology of cancer patients

  1976cited by this paper
• Antibody in the sera of tumor-bearing mice that mediates spleen cell cytotoxicity toward the autologous tumor.

  1976cited by this paper
• Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens

  1976cited by this paper
• Detection of tumor‐associated antigen in human melanoma cell line supernatants

  1976cited by this paper
• The immunoglobulins in Hodgkin's disease.

  1976cited by this paper
• NEW CHROMATOGRAPHIC APPROACHES TO THE SEPARATION OF HUMAN ALKALINE PHOSPHATASE ISOZYMES

  1975cited by this paper
• A microradioimmunoassay for antibodies to tumor-associated antigens.

  1975cited by this paper
• The release of high-molecular-weight alkaline phosphatase and leucine aminopeptidase into the media of cultured human cells.

  1975cited by this paper
• Letter: Embedded toenails.

  1975cited by this paper
• Proceedings: Escape from immune destruction by the host through shedding of surface antigens: is this a characteristic shared by malignant and embryonic cells?

  1974cited by this paper
• Double-antibody radioimmunoassay for B16 melanoma antibodies.

  1974cited by this paper
• Inhibition of Tumor-Induced Lymphocyte Blastogenesis by a Factor or Factors Associated with Peripheral Leukocytes

  1974cited by this paper
• The role of circulating antigen as an inhibitor of tumour immunity in man.

  1973cited by this paper
• Immunity to neuroblastomas and melanomas.

  1972cited by this paper
• The placental isoenzymes of alkaline phosphatase in sera of normal pregnancy.

  1972cited by this paper
• Immunological enhancement: a study of blocking antibodies.

  1972cited by this paper
• Immunoglobulin‐producing cells in human pericancerous lymph nodes

  1969cited by this paper
• IMMUNOGLOBULINS IN BURKITT'S LYMPHOMA

  1966cited by this paper
• Immunologic competence of mouse placental cells in irradiated hosts.

  1966cited by this paper
• Immunochemical quantitation of antigens by single radial immunodiffusion.

  1965cited by this paper
• Diffusion-in-gel methods for immunological analysis.

  1958cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Exosomal microRNA biomarkers in ovarian cancer detection: systematic review and meta-analysis.

  2025cites this paper
• Emerging technologies towards extracellular vesicles large-scale production

  2025cites this paper
• Exosomes in diagnostic and therapeutic applications of ovarian cancer

  2024cites this paper
• Identifying Serum Small Extracellular Vesicle MicroRNA as a Noninvasive Diagnostic and Prognostic Biomarker for Ovarian Cancer.

  2023cites this paper
• Extracellular vesicle interactions with the external and internal exposome in mediating carcinogenesis.

  2021cites this paper
• Early diagnosis of breast and ovarian cancers by body fluids circulating tumor-derived exosomes

  2020cites this paper
• Extracellular vesicles as critical mediators of maternal-fetal communication during pregnancy and their potential role in maternal metabolism.

  2020cites this paper
• Exosomes: Current Use and Future Applications.

  2019cites this paper
• Exosomes as critical mediators of cell-to-cell communication in cancer pathogenesis and their potential clinical application

  2019cites this paper
• The potential theragnostic (diagnostic+therapeutic) application of exosomes in diverse biomedical fields

  2018cites this paper
• NANOmetric BIO-Banked MSC-Derived Exosome (NANOBIOME) as a Novel Approach to Regenerative Medicine

  2018cites this paper
• Small RNAs in Circulating Exosomes of Cancer Patients: A Minireview

  2017cites this paper
• Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective

  2017cites this paper
• The biological significance and clinical applications of exosomes in ovarian cancer.

  2016cites this paper
• Biological Impact of Membranous Nanostructures

  2015cites this paper
• Exosomes and exosomal miRNAs in cardiovascular protection and repair.

  2015cites this paper
• Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes.

  2015cites this paper
• Modulation of the ovarian cancer humoral response by tumor-derived exosomes.

  2014cites this paper
• Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles.

  2014cites this paper
• The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids

  2013cites this paper
• Characterization of RNA in exosomes secreted by human breast cancer cell lines using next-generation sequencing

  2013cites this paper
• Circulating Cell-derived Vesicles Mediate Tumor Progression

  2013cites this paper
• Preeclampsia and MicroRNAs

  2013cites this paper
• Suppression of inflammation by tumor-derived exosomes: a kind of natural liposome packaged with multifunctional proteins

  2012cites this paper
• Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.

  2012cites this paper
• Exosomes: new players in cell-cell communication.

  2012cites this paper
• Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments

  2011cites this paper
• Heat shock proteins in ovarian cancer: a potential target for therapy.

  2010cites this paper
• Analysis of the expression of human tumor antigens in ovarian cancer tissues

  2009cites this paper
• Suppression of membrane microvesiculation--a possible anticoagulant and anti-tumor progression effect of heparin.

  2009cites this paper
• Number of microvesicles in peripheral blood and ability of plasma to induce adhesion between phospholipid membranes in 19 patients with gastrointestinal diseases.

  2008cites this paper
• Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system?

  2005cites this paper
• Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects

  2005cites this paper
• Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer.

  2001cites this paper
• Epitope recognition by anti-cathepsin D autoantibodies in endometrial cancer patients.

  2001cites this paper
• Tumor-reactive immunoglobulins in ovarian cancer: diagnostic and therapeutic significance? (review).

  1998cites this paper
• Cathepsin D antigenic epitopes identified by the humoral responses of ovarian cancer patients

  1998cites this paper
• Induction of Immune Responses to Ovarian Tumor Antigens by Multiparity

  1997cites this paper
• Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients.

  1997cites this paper
• Inhibition of interleukin-2 dependent immune responses by serum from patients with advanced gastrointestinal cancer.

  1993cites this paper
• Lymphokine-activated killer cell suppressor factor in malignant effusions.

  1991cites this paper
• Characterization of plasma membrane shedding from murine melanoma cells

  1988cites this paper
• Ovarian tumor antigens: preliminary histological investigation.

  1986cites this paper
• Shedding of plasma membrane fragments. Neoplastic and developmental importance.

  1986cites this paper
• Inhibition of macrophage Ia antigen expression by shed plasma membrane vesicles from metastatic murine melanoma lines.

  1985cites this paper
• Membrane vesicles shed by murine melanoma cells selectively inhibit the expression of Ia antigen by macrophages.

  1985cites this paper
• Inhibition of recombinant interferon-gamma-induced Ia antigen expression by shed B16 F10 melanoma cell membrane vesicles.

  1985cites this paper
• SHED MEMBRANE VESICLES: A MECHANISM FOR TUMOR-INDUCED IMMUNOSUPPRESSION

  1985cites this paper
• Quantitation of immunoglobulins in the effusions of human ovarian epithelial neoplasms.

  1984cites this paper
• Identification of Antigenic Components Recognized by “Membrane‐Bound” Antibodies From Ovarian Cancer Patients

  1984cites this paper
• Immunosuppressive Factors in Ascites Fluids From Ovarian Cancer Patients

  1984cites this paper